Thyroid Gland Disorder Treatment Market Revenue Projection and Future Growth: AbbVie, Pfizer, Merck, Lannett Company, Allergan, Mylan N.V, GlaxoSmithKline, Novartis and Abbott

The global thyroid gland disorder market was valued at $2,057 million in 2017, and is estimated to reach $2,771 million by 2025 at a CAGR of 3.8% from 2018 to 2025.

The key players operating in the global thyroid gland disorder treatment market include AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Lannett Company, Inc., Allergan plc, Mylan N.V., GlaxoSmithKline plc, Novartis AG, RLC LABS, Inc., and Abbott Laboratories.

Other prominent players in the value chain include Takeda Pharmaceutical Company Limited, Aspen, Amgen Inc., Endo International plc, Acella Pharmaceuticals, LLC, and Gemini Laboratories, LLC.

Get Sample PDF Brochure of Thyroid Gland Disorder Treatment Market Study at : https://www.alliedmarketresearch.com/request-sample/3762

Thyroid Gland Disorder Treatment Market is an endocrine gland that stimulates hormones, which help regulate the metabolism of the body. When the thyroid gland does not produce enough thyroid hormones (hypothyroidism) or too much hormone (hyperthyroidism), the metabolism and functioning of the body is disrupted. The lack of iodine in the body is a major factor that leads to thyroid disorder. It has been observed that more than 2 billion people are estimated to be at the risk of iodine deficiency worldwide, among which the developing countries have the highest number of undiagnosed patients.

The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder.

However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.

Disease type segment review

Based on the disease type, the market is bifurcated into hypothyroidism and hyperthyroidism. The hypothyroidism segment dominates the market, owing to the high prevalence of iodine deficiency population worldwide, and is the most commonly occurring thyroid disorder.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3762

Route of administration segment review

Based on route of administration, the market is classified into oral, intravenous, and others. Oral route of administration is the largest contributor toward the market growth as most of the medications available in the market are in the form of tablets or pills and can be easily administered by patients on daily basis.

Key geographical segment

As per region, the thyroid gland disorder treatment market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2017, and is expected to retain its dominance throughout the forecast period.

Key Benefits

• This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
• Market estimations are based on comprehensive analysis of the key developments in the industry.
• The global market is comprehensively analyzed with respect to disease type, drug type, route of administration, distribution channels, and region.
• In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
• The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Learn more : https://www.prnewswire.com/news-releases/thyroid-gland-disorder-treatment-market-worth-2-771-million-by-2025-cagr-3-8-allied-market-research-855031824.html

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.